文献速递腹部介入CTMR

钇-90放射段切除术治疗肝细胞癌的疗效与价值

Radiation segmentectomy for hepatocellular carcinoma: redefining the limits of curative-intent therapy.
PubMed 文献 · Br J Radiol · 2026-01-01

本文围绕钇-90微球放射段切除术治疗肝细胞癌展开,重点讨论其在早期病变中的根治意图应用。该技术可向肿瘤及邻近肝实质递送消融剂量,减少全身毒副反应并保留正常肝组织。文章还评价了影像学应答、病理坏死、移植桥接与降期作用。

要点

  • 放射段切除术适合早期肝细胞癌,影像学完全应答常对应病理坏死
  • 治疗后需按mRECIST和EASL标准评估肿瘤应答与局部控制
  • 该技术可用于肝移植前桥接和降期,提高移植候选资格

核心结论

  • 放射段切除术对早期肝细胞癌具有高客观应答和完全应答率,影像学应答与病理坏死密切相关
  • 该技术安全性好,严重并发症罕见,并可改善等待肝移植患者的管理与结局

研究设计与样本

  • 来源于Br J Radiol的文章,围绕钇-90微球放射段切除术在肝细胞癌中的应用进行论述
  • 原文未报告具体研究类型、样本量、中心数和设备序列参数

关键影像表现/征象

  • 治疗后可依据mRECIST和EASL标准观察到高客观应答及完全应答
  • 完全影像学应答常与肿瘤完全病理坏死直接相关
  • 常规不良事件通常轻微且短暂,提示治疗靶向性和微创性较好

诊断标准与关键数值

  • 采用modified Response Evaluation Criteria in Solid Tumors和European Association for the Study of the Liver标准评估影像学应答与病理坏死
  • 原文未报告敏感度、特异度、AUC、阈值及分级标准的具体数值

临床应用与阅片要点

  • 阅片时应重点评价肿瘤动脉期强化消失、廓清消失等符合mRECIST和EASL的应答表现
  • 肝移植桥接和降期患者需动态比较治疗前后肿瘤负荷变化
  • 影像随访中需注意鉴别治疗后改变与残存或复发病灶

局限性

  • 原文属于综述性质论述,未明确纳入研究数量和证据等级
  • 未提供具体不良反应发生率及其与剂量学关系的定量数据

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Radiation segmentectomy (RS) utilizing Yttrium-90 (Y90) microspheres has emerged as a highly effective, minimally invasive locoregional therapy for hepatocellular carcinoma (HCC), particularly in early-stage disease. This precision treatment delivers ablative radiation doses directly to the tumor and its immediate surrounding parenchyma, thereby minimizing systemic toxicity and preserving healthy liver tissue. RS consistently demonstrates high objective and complete response rates, which often correlate directly with complete pathological necrosis of the tumor, as rigorously assessed by the modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver criteria. This robust imaging response translates into durable local tumor control and prolonged time to disease progression. The safety and feasibility of RS are generally well established. The procedure is typically well tolerated, with common adverse events usually being mild and transient. Severe complications are rare, emphasizing the procedure's precision and minimal invasiveness. Optimal outcomes are contingent upon meticulous patient selection, strict adherence to technical guidelines, and precise dosimetry. Beyond its role as a definitive therapy, RS plays a critical function in bridging and downstaging patients awaiting liver transplantation. By effectively controlling tumor burden, it enhances patient eligibility for transplantation and improves outcomes on transplant waiting lists. Furthermore, RS offers distinct advantages over other conventional locoregional therapies in specific clinical scenarios, solidifying its integral position within the comprehensive management paradigm for HCC.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Bozzi, Bianchi, Lorenzoni, et al. Radiation segmentectomy for hepatocellular carcinoma: redefining the limits of curative-intent therapy. Br J Radiol. 2026. PMID: 42467837. doi:10.1093/bjr/tqag155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。